Cephalexin and Bamate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cephalexin (cephalexin) and Bamate (meprobamate). Common drug interactions include overdose among females and agitation among males.

The phase IV clinical study analyzes what interactions people have when they take Cephalexin and Bamate. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Cephalexin?

Cephalexin has active ingredients of cephalexin. It is often used in infection. eHealthMe is studying from 30,580 Cephalexin users. Check the latest studies of Cephalexin.

What is Bamate?

Bamate has active ingredients of meprobamate. eHealthMe is studying from 2,268 Bamate users. Check the latest studies of Bamate.



On Aug, 04, 2026

11 people who take Cephalexin and Bamate together, and have interactions are studied.

Cephalexin and Bamate drug interactions.

What are the common drug interactions of Cephalexin and Bamate, by gender? *:

female:

  1. Overdose
  2. Affective disorder (mental disorder)
  3. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  4. Pain
  5. Drug abuser
  6. Hepatic congestion (liver congestion)
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Papillary thyroid cancer
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Coma (state of unconsciousness lasting more than six hours)

male:

  1. Agitation (state of anxiety or nervous excitement)
  2. Cardiac failure
  3. Asthenia (weakness)
  4. Cardiac failure congestive
  5. Fatigue (feeling of tiredness)
  6. Loss of employment
  7. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  8. Blood glucose increased
  9. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  10. Chest discomfort

What are the common drug interactions of Cephalexin and Bamate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hepatic congestion (liver congestion)
  2. Papillary thyroid cancer
  3. Coma (state of unconsciousness lasting more than six hours)
  4. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  5. Diverticulitis intestinal (digestive disease which involves the formation of pouches (diverticula) within the intestinal wall)
  6. Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
  7. Overdose
  8. Ventricular hypertrophy (enlargement of ventricles (lower chambers) in the heart)

40-49:

  1. Arteriosclerosis (thickening and hardening of arteries)
  2. Drug administration error
  3. Dyspnoea (difficult or laboured respiration)
  4. Overdose

50-59:

  1. Affective disorder (mental disorder)
  2. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  3. Overdose
  4. Pain
  5. Drug abuser
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

60+:

  1. Agitation (state of anxiety or nervous excitement)
  2. Cardiac failure
  3. Cardiac failure congestive
  4. Dyspnoea (difficult or laboured respiration)
  5. Fatigue (feeling of tiredness)
  6. Loss of employment
  7. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  8. Blood glucose increased
  9. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  10. Chest discomfort

What are the existing conditions these people have? *

  1. Pain: 4 people, 36.36%
  2. Sleep Disorder: 3 people, 27.27%
  3. Upper Respiratory Tract Infection: 1 person, 9.09%
  4. Dizziness: 1 person, 9.09%
  5. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 9.09%
  6. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 9.09%
  7. Depression: 1 person, 9.09%
  8. Diabetes: 1 person, 9.09%
  9. Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 1 person, 9.09%
  10. High Blood Cholesterol: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cephalexin and Bamate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cephalexin and Bamate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cephalexin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bamate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cephalexin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bamate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cephalexin and meprobamate (the active ingredients of Cephalexin and Bamate, respectively), and Cephalexin and Bamate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: